Pentoxifylline in human immunodeficiency virus- positive tuberculosis: safety at 4 years.
Wallis
R S
RS
Johnson
J L
JL
Okwera
A
A
Nsubuga
P
P
Whalen
C C
CC
Mugerwa
R D
RD
Ellner
J J
JJ
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000401:mortality; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D010431:Pentoxifylline / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D012449:Safety; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000401:mortality; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D014409:Tumor Necrosis Factor-alpha; D010431:Pentoxifylline